Search Results - "Gianoncelli, Letizia"

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey by Catania, Chiara, Spitaleri, Gianluca, Del Signore, Ester, Attili, Ilaria, Radice, Davide, Stati, Valeria, Gianoncelli, Letizia, Morganti, Stefania, de Marinis, Filippo

“…In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a…”
Get full text

Solitude and fear during the great coronavirus war by Catania, Chiara, Del Signore, Ester, gianoncelli, letizia

“…When you get ill, the first thing that comes to your mind is, “Will I make it? Will I survive?". COVID19 has a major impact on mental health. A sadness that…”
Get full text

Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model by de Marinis, Filippo, Attili, Ilaria, Morganti, Stefania, Stati, Valeria, Spitaleri, Gianluca, Gianoncelli, Letizia, Del Signore, Ester, Catania, Chiara, Rampinelli, Cristiano, Omodeo Salè, Emanuela, Spaggiari, Lorenzo, Mastrilli, Fabrizio, Passaro, Antonio

“…A novel coronavirus causing severe acute respiratory syndrome (SARS), named SARS-CoV-2, was identified at the end of 2019. The spread of coronavirus disease…”
Get full text

Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease by Toschi, Luca, Finocchiaro, Giovanna, Nguyen, Teresa T, Skokan, Margaret C, Giordano, Laura, Gianoncelli, Letizia, Perrino, Matteo, Siracusano, Licia, Di Tommaso, Luca, Infante, Maurizio, Alloisio, Marco, Roncalli, Massimo, Scorsetti, Marta, Jänne, Pasi A, Santoro, Armando, Varella-Garcia, Marileila

“…We aimed to investigate prevalence and prognostic role of SOX2, PIK3CA, FGFR1 and BRF2 gene gain in patients with surgically resected non-small cell lung…”
Get full text

What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences by Petrocchi, Serena, Janssens, Rosanne, Oliveri, Serena, Arnou, Reinhard, Durosini, Ilaria, Guiddi, Paolo, Louis, Evelyne, Vandevelde, Marie, Nackaerts, Kristiaan, Smith, Meredith Y, Galli, Giulia, de Marinis, Filippo, Gianoncelli, Letizia, Pravettoni, Gabriella, Huys, Isabelle

“…The potential value of patient preference studies has been recognized in clinical individual treatment decision-making between clinicians and patients, as well…”
Get full text

Second-line treatment for malignant pleural mesothelioma by Ceresoli, Giovanni Luca, Zucali, Paolo Andrea, Gianoncelli, Letizia, Lorenzi, Elena, Santoro, Armando

“…Summary Most patients affected by malignant pleural mesothelioma (MPM) are candidates for chemotherapy during the course of the disease, as single modality…”
Get full text

Clinical staging of malignant pleural mesothelioma: current perspectives by Bonomi, Maria, De Filippis, Costantino, Lopci, Egesta, Gianoncelli, Letizia, Rizzardi, Giovanna, Cerchiaro, Eleonora, Bortolotti, Luigi, Zanello, Alessandro, Ceresoli, Giovanni Luca

“…Malignant pleural mesothelioma (MPM) is a disease with limited therapeutic options, the management of which is still controversial. Diagnosis is usually made…”
Get full text

Tumour Treating Fields for mesothelioma – Authors' reply by Ceresoli, Giovanni L, Gianoncelli, Letizia, Grosso, Federica

“…Patients had incidental diagnosis of malignant pleural mesothelioma and were not part of a screening programme; the majority of them were enrolled in…”
Get full text

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data by Passaro, Antonio, Attili, Ilaria, Morganti, Stefania, Del Signore, Ester, Gianoncelli, Letizia, Spitaleri, Gianluca, Stati, Valeria, Catania, Chiara, Curigliano, Giuseppe, de Marinis, Filippo

“…•The ICIs, alone or in combination with other agents, dramatically changed the treatment scenario in metastatic NSCLC.•The role of sex as a predictor of…”
Get full text

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial by Ceresoli, Giovanni L, Aerts, Joachim G, Dziadziuszko, Rafal, Ramlau, Rodryg, Cedres, Susana, van Meerbeeck, Jan P, Mencoboni, Manlio, Planchard, David, Chella, Antonio, Crinò, Lucio, Krzakowski, Maciej, Rüssel, Jörn, Maconi, Antonio, Gianoncelli, Letizia, Grosso, Federica

“…Tumour Treating Fields (TTFields) are a regional, antimitotic treatment for solid tumours, which is based on the delivery of low-intensity alternating electric…”
Get full text

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial by Pinto, Carmine, Zucali, Paolo Andrea, Pagano, Maria, Grosso, Federica, Pasello, Giulia, Garassino, Marina Chiara, Tiseo, Marcello, Soto Parra, Hector, Grossi, Francesco, Cappuzzo, Federico, de Marinis, Filippo, Pedrazzoli, Paolo, Bonomi, Maria, Gianoncelli, Letizia, Perrino, Matteo, Santoro, Armando, Zanelli, Francesca, Bonelli, Candida, Maconi, Antonio, Frega, Stefano, Gervasi, Erika, Boni, Luca, Ceresoli, Giovanni Luca

“…There is a preclinical rationale for inhibiting angiogenesis in mesothelioma. We aimed to assess the efficacy and safety of the anti-VEGFR-2 antibody…”
Get full text

Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach by Ceresoli, Giovanni Luca, Rossi, Giulio, Agustoni, Francesco, Bonomi, Lucia, Borghetti, Paolo, Bulotta, Alessandra, Casartelli, Clelia, Cerea, Giulio, Colonese, Francesca, del Signore, Ester, Finocchiaro, Giovanna, Gianoncelli, Letizia, Grisanti, Salvatore, Maiolani, Martina, Pagni, Fabio, Proto, Claudia, Rijavec, Erika, Vittimberga, Isabella, Arcangeli, Stefano, Filippi, Andrea Riccardo

“…Immunotherapy represented a turning point for treating extensive small-cell lung cancer (ES-SCLC). Although, many issues remain debated. A group of Italian…”
Get full text

Prognostic and predictive value of MET deregulation in non-small cell lung cancer by Finocchiaro, Giovanna, Toschi, Luca, Gianoncelli, Letizia, Baretti, Marina, Santoro, Armando

“…Recent progress in cancer biology has led to the discovery of increasing number of oncogene alterations that have dramatically changed the paradigm of lung…”
Get full text

Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis by Gianoncelli, Letizia, Spitaleri, Gianluca, Passaro, Antonio, Radice, Davide, Fumagalli, Caterina, Del Signore, Ester, Stati, Valeria, Catania, Chiara Matilde, Guerini-Rocco, Elena, Barberis, Massimo, DE Marinis, Filippo

“…The role of anti-PD1/PD-L1 therapy (IO) in NSCLC harboring driver mutations is questionable. This study aimed to examine the efficacy of IO in patients with…”
Get full text

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma by Ceresoli, Giovanni L, Zucali, Paolo A, De Vincenzo, Fabio, Gianoncelli, Letizia, Simonelli, Matteo, Lorenzi, Elena, Ripa, Cristina, Giordano, Laura, Santoro, Armando

“…Abstract The role of second-line therapy in patients with malignant pleural mesothelioma (MPM) progressing after first-line pemetrexed-based chemotherapy (PBC)…”
Get full text

Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma by Lopci, Egesta, Zucali, Paolo Andrea, Ceresoli, Giovanni Luca, Perrino, Matteo, Giordano, Laura, Gianoncelli, Letizia, Lorenzi, Elena, Gemelli, Maria, Santoro, Armando, Chiti, Arturo

“…Purpose Quantitative analyses on FDG PET for response assessment are increasingly used in clinical studies, particularly with respect to tumours in which…”
Get full text

Brain metastases in EGFR-positive non-small cell lung cancer: the way to the sanctuary becomes less winding by Passaro, Antonio, Gianoncelli, Letizia, Stati, Valeria, de Marinis, Filippo

Get full text

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin by ANDREA ZUCALI, Paolo, GIOVANNETTI, Elisa, BRUZZONE, Andrea, THUNNISSEN, Erik, TUNESI, Gianni, GIORDANO, Laura, RONCALLI, Massimo, PETERS, Godefridus J, SANTORO, Armando, DESTRO, Annarita, MENCOBONI, Manlio, LUCA CERESOLI, Giovanni, GIANONCELLI, Letizia, LORENZI, Elena, DE VINCENZO, Fabio, SIMONELLI, Matteo, PERRINO, Matteo

“…The pemetrexed/platinum agent combination represents the standard of care in first-line treatment for malignant pleural mesothelioma (MPM). However, there are…”
Get full text

Novel mutations in sporadic typical carcinoids of the lung (lung-TC): Tumor genomic profile by next generation sequencing (NGS) by Sullivan, Ivana GABRIELA, Lacroix, Ludovic, Adam, Julien, Honore, Aurelie, Dorvault, Nicolas, Gianoncelli, Letizia, Le Teuff, Gwenael, Besse, Benjamin, Soria, Jean-Charles, de Montpreville, Vincent, Scoazec, Jean-Yves, Baudin, Eric, Planchard, David

“…Abstract only…”
Get full text

Prognostic and predictive role of [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up‐front pemetrexed‐based chemotherapy by Zucali, Paolo Andrea, Lopci, Egesta, Ceresoli, Giovanni Luca, Giordano, Laura, Perrino, Matteo, Ciocia, Gianluigi, Gianoncelli, Letizia, Lorenzi, Elena, Simonelli, Matteo, De Vincenzo, Fabio, Setti, Lucia Rebecca, Bonifacio, Cristiana, Bonomi, Maria, Bombardieri, Emilio, Chiti, Arturo, Santoro, Armando

“…The aim of this study was to evaluate the role of metabolic parameters analyzed at baseline and at interim FDG‐PET in predicting disease outcome in…”
Get full text